<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-vaccines-08-00273">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yusim</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Fischer</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Yoon</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Thurmond</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Fenimore</surname>
    <given-names>P.W.</given-names>
   </name>
   <name>
    <surname>Lauer</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Korber</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Kuiken</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity</article-title>
  <source>J. Gen. Virol.</source>
  <year>2010</year>
  <volume>91</volume>
  <fpage>1194</fpage>
  <lpage>1206</lpage>
  <pub-id pub-id-type="doi">10.1099/vir.0.017491-0</pub-id>
  <pub-id pub-id-type="pmid">20053820</pub-id>
 </element-citation>
</ref>
